Abstract:
ob<x>jective:To investigate the efficacy of laparoscopic sleeve gastrectomy (LSG) in the treatment of obesity with essential hypertension. Methods: Retrospective analyze the clinical data and follow-up data of 60 patients with obesity and hypertension who underwent LSG in the Affiliated Hospital of Xuzhou Medical University from July 2013 to August 2018, record and compare the improvement and remission of hypertension before and after 1 year of operation. Results: 60 patients with obesity and hypertension were successfully completed laparoscopic sleeve gastrectomy (LSG), of which 30 males, 30 females, aged 16 to 60 years, mean age (36.9 ± 9.7) years old. 42 patients had complete remission of hypertension at 1 year after surgery, and the remission rate was 70%.The patients’ body weight decreased from (120.3±25.1) kg to (84.5±14.9)kg (t=18.331, P<0.001); body mass index (BMI) decreased from (40.8±6.7) kg/m2 to (28.7±3.9)kg/m2(t=19.988,P<0.001);blood pressure decreased from (154.8±16.7)/(101.0±14.2)mmHg to (125.8±9.3)/(81.4±7.0) ) mmHg (P < 0.001). The remission of hypertension after LSG is related to the duration of hypertension, grade of hypertension, the level of systolic and diastolic blood pressure before surgery, and whether or not to take medication before surgery (P <0.05), it is related to the age, gender, preoperative BMI, whether they were combined with other me<x>tabolic syndromes before surgery and the percentage of excess weight loss (% EWL) in patients at 1 year after surgery (P> 0.05). Conclusion:1. Laparoscopic sleeve gastrectomy has high safety, significant weight loss effect, and exact effect on hypertension; 2.LSG for obese patients with long duration, high grade, high degree of hypertension or need oral antihypertensive drugs to control blood pressure before operation, the antihypertensive effect is not good.